NSE · PANACEABIO
Panacea Biotec Limited (PANACEABIO) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,194
of 5,047 stocks
▼ 101W▼ 111M
Peak #1,159 · 27 Sep 2026
Panacea Biotec Limited is a smallcap company in the Healthcare space and has a subdued return on equity, remains firmly promoter-controlled, with promoters holding 72%, and is growing revenue at a solid clip.
Market Cap
2,155.31 Cr
P/E Ratio
—
P/B Ratio
2.60
ROE
-0.86%
ROCE
-2.28%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 189.67 Cr | 199.57 Cr | 166.75 Cr | 165.19 Cr |
| Net Profit | 11.91 Cr | 2.20 Cr | -1.00 Cr | 3.89 Cr |
| EPS | 1.90 | 0.38 | 0.08 | 0.65 |
| Operating Profit | 14.82 Cr | 2.01 Cr | -2.76 Cr | 5.57 Cr |
Shareholding pattern
Promoter
72.48%
Public
27.52%
PUBLIC BREAKDOWN
FII
2.31%
DII
2.25%
MF (within DII)
0.00%
Individuals
16.73%
Mutual fund holdings
₹0.02
Cr total
2
Schemes
2
Fund Houses
₹0.02 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (67.6%)
Bandhan Mutual Fund₹0.01 Cr (32.4%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 19 Sep 2022 | Other | Annual General Meeting |
| 16 Sep 2021 | Other | Annual General Meeting |
| 15 Dec 2020 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.